![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Tessera Launches New Prostate Cancer Test
Tessera Launches New Prostate Cancer Test
March 29, 2005
Tessera, a Seattle-based biomedical company, has released its first product, ProstaMark EPCA (Early Prostate Cancer Antigen), as an analyte specific reagent for commercial use in pathology laboratories to assist pathologists in their efforts to determine if cancer is present in the prostate.
Yahoo News (http://biz.yahoo.com/prnews/050328/sfm026.html?.v=4)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct